Schwartz Stephen G, Hickey Marcela, Puliafito Carmen A
Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida 34102, USA.
Ophthalmic Surg Lasers Imaging. 2006 Sep-Oct;37(5):420-2. doi: 10.3928/15428877-20060901-10.
A patient with thrombotic thrombocytopenic purpura secondary to adult-onset Still's disease presented with bilateral combined central retinal artery occlusion and central retinal vein occlusion, a rare complication reported only once before. Fundus appearance and fluorescein angiography were similar to the previous case. Optical coherence tomography findings demonstrated aspects consistent with both central retinal artery occlusion and central retinal vein occlusion. Treatment of one eye with intravitreal triamcinolone acetonide (4 mg) was not effective in improving visual acuity. Treatment of both eyes with intravitreal bevacizumab (1.25 mg) and panretinal photocoagulation was effective in eliminating iris neovascularization, although the patient lost all visual function.
一名继发于成人斯蒂尔病的血栓性血小板减少性紫癜患者出现双侧视网膜中央动脉阻塞合并视网膜中央静脉阻塞,这是一种此前仅报道过一次的罕见并发症。眼底表现和荧光素血管造影与之前的病例相似。光学相干断层扫描结果显示出与视网膜中央动脉阻塞和视网膜中央静脉阻塞均相符的特征。用玻璃体内注射曲安奈德(4毫克)治疗一只眼睛对提高视力无效。用玻璃体内注射贝伐单抗(1.25毫克)和全视网膜光凝治疗双眼对消除虹膜新生血管有效,尽管患者失去了所有视觉功能。